HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Kirsten Finucane Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cormack, B. E. Articles by West, T. M. Search for Related Content PubMed PubMed Citation Articles by Cormack, B. E. Articles by West, T. M. Related Collections Pleura

Ann Thorac Surg 2004;77:301-305
© 2004 The Society of Thoracic Surgeons

---

Original article: general thoracic

Use of Monogen for pediatric postoperative chylothorax

^a Nutrition Services, Green Lane Hospital, Auckland, New Zealand
^b Pediatric Cardiology Department, Green Lane Hospital, Auckland, New Zealand
^c Cardiothoracic Surgical Unit, Green Lane Hospital, Auckland, New Zealand
^d Biostatistics Department, Green Lane Hospital, Auckland, New Zealand

Accepted for publication July 1, 2003.

^* Address reprint requests to Ms Cormack, Nutrition Services, Green Lane Hospital, Greenlane West, Auckland 1030, New Zealand.
e-mail: bcormack{at}adhb.govt.nz

BACKGROUND: Postoperative chylothorax is a potentially serious complication of pediatric cardiac surgery. The purpose of this study was to report the use of Monogen enteral formula for the management of pediatric postoperative chylothorax.

METHODS: A retrospective, single-institution 2-year study of all patients with a diagnosis of postoperative chylothorax was conducted. Chylothorax was diagnosed in 25 patients after a total of 535 cardiac operations in children younger than 10 years, for an incidence of 4.7%. Eighteen patients had been given Monogen, an enteral low long-chain triglyceride formula, as initial treatment. Six had been given total parenteral nutrition. The following variables were related to outcome and response to Monogen: age, sex, weight, underlying condition, type of surgery, interval between surgery and chylothorax diagnosis, duration and daily volume of chyle leak, central venous pressure, residual lesions, and weight loss.

RESULTS: Enteral feeding with Monogen was successful for 14 of 18 patients with a response to treatment evident by the end of the third day. No variables predicted which patients would respond to Monogen. Body weight was maintained or increased in 14 of the 17 surviving patients taking Monogen. A return to normal diet at 4 ± 1 weeks from the day of pleural drain removal did not result in recurrent chylothorax.

CONCLUSIONS: A trial of Monogen is recommended as initial treatment for postoperative chylothorax unless enteral feeding is contraindicated.

This article has been cited by other articles:

				S.-y. Chan, W. Lau, W. H.S. Wong, L.-c. Cheng, A. K.T. Chau, and Y.-f. Cheung Chylothorax in Children After Congenital Heart Surgery Ann. Thorac. Surg., November 1, 2006; 82(5): 1650 - 1656. [Abstract] [Full Text] [PDF]

				E. H. Chan, J. L. Russell, W. G. Williams, G. S. Van Arsdell, J. G. Coles, and B. W. McCrindle Postoperative Chylothorax After Cardiothoracic Surgery in Children Ann. Thorac. Surg., November 1, 2005; 80(5): 1864 - 1870. [Abstract] [Full Text] [PDF]